In the case of DM, excessive cytokines, inflammatory factors and oxidative stress responses potentially alter the expressions and activities of endothelial NO synthase (eNOS) and cyclooxygenase-2 (COX2), which decrease the bioavailability of NO and prostacyclin (PGI2), thereby appearing to be responsible for EDR damage. The gene discussed is PTGS2; the disease is diabetes mellitus.